These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 19285154
1. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Rönnelid J, Barbasso Helmers S, Storfors H, Grip K, Rönnblom L, Franck-Larsson K, Nordmark G, Lundberg IE. Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154 [Abstract] [Full Text] [Related]
2. Clinical implications of autoantibody screening in patients with autoimmune myositis. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655 [Abstract] [Full Text] [Related]
3. Immunoserological aspects of idiopathic inflammatory muscle disease. Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T. Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964 [Abstract] [Full Text] [Related]
4. [Diagnostic significance of scleroderma and myositis-associated autoantibodies]. Genth E, Mierau R. Z Rheumatol; 1995 Aug 25; 54(1):39-49. PubMed ID: 7725809 [Abstract] [Full Text] [Related]
5. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Defendenti C, Atzeni F, Spina MF, Grosso S, Cereda A, Guercilena G, Bollani S, Saibeni S, Puttini PS. Autoimmun Rev; 2011 Jan 25; 10(3):150-4. PubMed ID: 20854935 [Abstract] [Full Text] [Related]
6. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Srivastava P, Dwivedi S, Misra R. Rheumatol Int; 2016 Jul 25; 36(7):935-43. PubMed ID: 27193471 [Abstract] [Full Text] [Related]
7. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Yamamoto AM, Amoura Z, Johannet C, Jeronimo AL, Campos H, Koutouzov S, Piette JC, Bach JF. Arthritis Rheum; 2000 Mar 25; 43(3):689-98. PubMed ID: 10728764 [Abstract] [Full Text] [Related]
8. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Arthritis Rheum; 2004 Jan 25; 50(1):209-15. PubMed ID: 14730618 [Abstract] [Full Text] [Related]
9. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes]. Meurer M, Hausmann-Martinez-Pardo G, Braun-Falco O. Hautarzt; 1989 Oct 25; 40(10):623-9. PubMed ID: 2482267 [Abstract] [Full Text] [Related]
10. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. J Rheumatol; 2005 Aug 25; 32(8):1488-94. PubMed ID: 16078324 [Abstract] [Full Text] [Related]
11. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods]. Villalta D, Bizzaro N, Tonutti E, Visentin D, Manoni F, Piazza A, Toffolo L, Rizzotti P, Clemen P, Pradella M, Bassetti D, Tozzoli R. Recenti Prog Med; 1999 Nov 25; 90(11):579-84. PubMed ID: 10608146 [Abstract] [Full Text] [Related]
12. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K, Hoch S, Dima C, Varga J, Teodorescu M. J Rheumatol; 2000 Jan 25; 27(1):142-8. PubMed ID: 10648030 [Abstract] [Full Text] [Related]
13. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M. Arthritis Rheum; 2006 Oct 15; 55(5):791-8. PubMed ID: 17013837 [Abstract] [Full Text] [Related]
14. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. Dorner T, Feist E, Wagenmann A, Kato T, Yamamoto K, Nishioka K, Burmester GR, Hiepe F. J Rheumatol; 1996 Mar 15; 23(3):462-8. PubMed ID: 8832984 [Abstract] [Full Text] [Related]
15. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW. Ann N Y Acad Sci; 2005 Jun 15; 1050():340-7. PubMed ID: 16014550 [Abstract] [Full Text] [Related]
16. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies]. Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J. Presse Med; 2010 Oct 15; 39(10):1010-25. PubMed ID: 20655695 [Abstract] [Full Text] [Related]
17. Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre. Martel C, Vignaud G, Liozon E, Magy L, Gallouedec G, Ly K, Bezanahary H, Cypierre A, Lapébie FX, Palat S, Gondran G, Jauberteau MO, Fauchais AL. Clin Exp Rheumatol; 2016 Oct 15; 34(5):918-924. PubMed ID: 27494325 [Abstract] [Full Text] [Related]
18. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. Frank MB, McCubbin V, Trieu E, Wu Y, Isenberg DA, Targoff IN. J Autoimmun; 1999 Mar 15; 12(2):137-42. PubMed ID: 10047434 [Abstract] [Full Text] [Related]
19. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL. Arthritis Res Ther; 2007 Mar 15; 9(4):R78. PubMed ID: 17688695 [Abstract] [Full Text] [Related]
20. The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders. Gofrit SG, Yonath H, Lidar M, Shoenfeld Y, Kivity S. Clin Rheumatol; 2018 May 15; 37(5):1257-1263. PubMed ID: 29453582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]